Literature DB >> 15342727

Glyceraldehyde-3-phosphate dehydrogenase is a GABAA receptor kinase linking glycolysis to neuronal inhibition.

Jacques J Laschet1, Frédéric Minier, Irène Kurcewicz, Michel H Bureau, Suzanne Trottier, Freddy Jeanneteau, Nathalie Griffon, Bart Samyn, Jozef Van Beeumen, Jacques Louvel, Pierre Sokoloff, René Pumain.   

Abstract

Protein phosphorylation is crucial for regulating synaptic transmission. We describe a novel mechanism for the phosphorylation of the GABA(A) receptor, which mediates fast inhibition in the brain. A protein copurified and coimmunoprecipitated with the phosphorylated receptor alpha1 subunit; this receptor-associated protein was identified by purification and microsequencing as the key glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Molecular constructs demonstrated that GAPDH directly phosphorylates the long intracellular loop of GABA(A) receptor alpha1 subunit at identified serine and threonine residues. GAPDH and the alpha1 subunit were found to be colocalized at the neuronal plasma membrane. In keeping with the GAPDH/GABA(A) receptor molecular association, glycolytic ATP produced locally at plasma membranes was consumed for this alpha1 subunit phosphorylation, possibly within a single macrocomplex. The membrane-attached GAPDH is thus a dual-purpose enzyme, a glycolytic dehydrogenase, and a receptor-associated kinase. In acutely dissociated cortical neurons, the rundown of the GABA(A) responses was essentially attributable to a Mg(2+)-dependent phosphatase activity, which was sensitive to vanadate but insensitive to okadaic acid or fluoride. Rundown was significantly reduced by the addition of GAPDH or its reduced cofactor NADH and nearly abolished by the addition of its substrate glyceraldehyde-3-phosphate (G3P). The prevention of rundown by G3P was abolished by iodoacetamide, an inhibitor of the dehydrogenase activity of GAPDH, indicating that the GABA(A) responses are maintained by a glycolysis-dependent phosphorylation. Our results provide a molecular mechanism for the direct involvement of glycolysis in neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342727      PMCID: PMC6729617          DOI: 10.1523/JNEUROSCI.0868-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  31 in total

1.  Quantitative proteomics analysis of phosphorylated proteins in the hippocampus of Alzheimer's disease subjects.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Eugenio Barone; Marzia Perluigi; Chiara Cini; Cesare Mancuso; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-04-13       Impact factor: 4.044

2.  Conserved toxic responses across divergent phylogenetic lineages: a meta-analysis of the neurotoxic effects of RDX among multiple species using toxicogenomics.

Authors:  Natàlia Garcia-Reyero; Tanwir Habib; Mehdi Pirooznia; Kurt A Gust; Ping Gong; Chris Warner; Mitchell Wilbanks; Edward Perkins
Journal:  Ecotoxicology       Date:  2011-03-29       Impact factor: 2.823

3.  Anticonvulsant and antiepileptic actions of 2-deoxy-D-glucose in epilepsy models.

Authors:  Carl E Stafstrom; Jeffrey C Ockuly; Lauren Murphree; Matthew T Valley; Avtar Roopra; Thomas P Sutula
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

4.  A novel unbiased proteomic approach to detect the reactivity of cerebrospinal fluid in neurological diseases.

Authors:  Krishnakumar N Menon; David L Steer; Martin Short; Steven Petratos; Ian Smith; Claude C A Bernard
Journal:  Mol Cell Proteomics       Date:  2011-03-18       Impact factor: 5.911

5.  Metabolite concentration changes associated with positive and negative BOLD responses in the human visual cortex: A functional MRS study at 7 Tesla.

Authors:  Yohan Boillat; Lijing Xin; Wietske van der Zwaag; Rolf Gruetter
Journal:  J Cereb Blood Flow Metab       Date:  2019-02-12       Impact factor: 6.200

6.  Neuroprotective effect of grape seed extract on brain ischemia: a proteomic approach.

Authors:  Safwen Kadri; Mohamed El Ayed; Pascal Cosette; Thierry Jouenne; Salem Elkhaoui; Sami Zekri; Ferid Limam; Ezzedine Aouani; Meherzia Mokni
Journal:  Metab Brain Dis       Date:  2019-02-22       Impact factor: 3.584

7.  On-site energy supply at synapses through monocarboxylate transporters maintains excitatory synaptic transmission.

Authors:  Masashi Nagase; Yukari Takahashi; Ayako M Watabe; Yoshihiro Kubo; Fusao Kato
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

8.  A novel variant in the 3' UTR of human SCN1A gene from a patient with Dravet syndrome decreases mRNA stability mediated by GAPDH's binding.

Authors:  Tao Zeng; Zhao-Fei Dong; Shu-Jing Liu; Rui-Ping Wan; Ling-Jia Tang; Ting Liu; Qi-Hua Zhao; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao; Yue-Sheng Long
Journal:  Hum Genet       Date:  2014-01-25       Impact factor: 4.132

9.  Glycolytic Enzymes Localize to Synapses under Energy Stress to Support Synaptic Function.

Authors:  SoRi Jang; Jessica C Nelson; Eric G Bend; Lucelenie Rodríguez-Laureano; Felipe G Tueros; Luis Cartagenova; Katherine Underwood; Erik M Jorgensen; Daniel A Colón-Ramos
Journal:  Neuron       Date:  2016-04-07       Impact factor: 17.173

10.  Interfering with glycolysis causes Sir2-dependent hyper-recombination of Saccharomyces cerevisiae plasmids.

Authors:  Markus Ralser; Ute Zeidler; Hans Lehrach
Journal:  PLoS One       Date:  2009-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.